A case of Guillain-Barré syndrome following COVID-19 infection

The Covid-19 pandemic started in December 2019 and revealed various symptoms and complications, including neurological complications. Recently studies have suggested a possible link between this viral infection and Guillain-Barré syndrome (GBS).

Case Description: 

In this report, we present a patient who after being diagnosed with Covid-19 disease, suffers from ascending peripheral neuropathy. Various diagnostic procedures support the diagnosis of GBS.

After treatment with plasmapheresis, an acceptable response to treatment was observed.

Given the viral nature of COVID-19 disease and the evidence of GBS association with viral diseases, as well as the possibility of disease invasion to the respiratory system, if neurological symptoms begin in a COVID-19 patient, GBS should be included in the differential diagnosis.